Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
dorsaVi Limited ( (AU:DVL) ) has shared an update.
dorsaVi has announced a five-year sales agreement with Select Medical, a leading US-based network of outpatient physical therapy centers, to offer its FDA-approved products across over 1,900 locations. This partnership follows an 18-month development pilot that ensured the technology met therapists’ needs, focusing on rehabilitation and return-to-play assessments for injured athletes. The agreement marks a significant opportunity for dorsaVi to enhance its presence in the US market, potentially impacting patient assessment and rehabilitation practices.
More about dorsaVi Limited
dorsaVi Ltd is an ASX-listed company specializing in innovative motion analysis device technologies for clinical applications, elite sports, and occupational health and safety. Their wearable sensor technology allows detailed human movement and position to be accurately captured and assessed outside a biomechanics lab in real-time and real situations for up to 24 hours.
Average Trading Volume: 6,464,599
Technical Sentiment Signal: Buy
Current Market Cap: A$50.64M
See more insights into DVL stock on TipRanks’ Stock Analysis page.